Loading
Latest filing published 01 Sept 2022 for PaxMedica, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of TardiMed Sciences LLC across 2 companies, led by Timber Pharmaceuticals, Inc. and PaxMedica, Inc. The record holds 27 filings, for trades running from 10 February 2020 to 30 August 2022.
In open-market terms, that means 1 purchase worth €498k on one side and 24 sales worth €1.9M on the other. On balance, insiders were net sellers of €1.4M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 1 share grant. So far in 2022, the count stands at 1 purchase and no sales.
Most recently, on 1 September 2022, the filings show an open-market purchase worth €498k in PaxMedica, Inc. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations